BioNukleo is part of the Network for Pharma Solutions -NetPhaSol 

 

 

We proudly announce the start of „Network for Pharma Solutions – NetPhaSol“. This cooperation network for drug development serves as a platform for research, development and marketing of new products, processes and services. The primary focus are the first value chain stages of a drug development cycle - however, further development stages are not excluded. BioNukleo is now broadening NetPhaSol´s profile with its expertise in Drug development. The initiative will present its portfolio at the drug development meeting „Treffpunkt Wirkstoffentwicklung“ on 16th October in Berlin. More information you can find here.

 

Source: Berlin Partner for Business and Technology GmbH

 

BioNukleo was at "1st Symposium on Nucleic Acid Modifications" in Mainz 4- 6 September 2017

Most of the symposium was dedicated to plenary lectures from invited speakers as well as short talks. There also were poster sessions where selected participants could present their research. The schedule also included social activities, such as a welcome reception/dinner, lunch and coffee breaks as well as a guided city tour.

BioNukleo at Bionnale

Consectetur adipiscing elit. Inscite autem medicinae et gubernationis ultimum cum ultimo sapientiae comparatur.

BioNukleo at German Biotechnology days

Consectetur adipiscing elit. Inscite autem medicinae et gubernationis ultimum cum ultimo sapientiae comparatur.

Label "Innovative through research"

From the german "Stifterverband", BioNukleo gets the label "Innovative through research due to it's high expenses in biocatalytic research.


BioNukleo was at BioTechnika

Together with Labvolution, the Biotechnika was in May 16-18 in Hannover, Germany. The specialist trade fair for innovative lab equipment and laboratory workflow optimization "LABVOLUTION with Life Science Event BIOTECHNICA" has a new thematic focus. BioNukleo made contact to customers, distributers and had a close look at the new smart lab- showing the future of molecular biology. In fact, BioNukleo has also access to the lab of the future from the TU Berlin, with different robots facilitation scientist´s work.